These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1307202)
1. [Prevalence of antibodies to hepatitis C (anti HCV) in blood donors in Rio de Janeiro, Brazil. Its relation to ALT and anti HBC]. Leite NC; Nogueira CM; Coelho HS; Perez R; Martins SJ; Soares JA; Junqueira PC Arq Gastroenterol; 1992; 29(1):5-11. PubMed ID: 1307202 [TBL] [Abstract][Full Text] [Related]
2. Missed opportunities: ALT and anti-HBc as surrogate tests for hepatitis. Bettigole R; Shastri KA J Med; 1997; 28(5-6):363-9. PubMed ID: 9604794 [TBL] [Abstract][Full Text] [Related]
3. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria. Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of mandatory transmissible diseases screening in Indian blood donors. Choudhury N; Ramesh V; Saraswat S; Naik S Indian J Med Res; 1995 Jun; 101():229-32. PubMed ID: 7672831 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of blood-borne viruses: a study of healthy blood donors in Southern Pakistan. Kakepoto GN; Bhally HS; Khaliq G; Kayani N; Burney IA; Siddiqui T; Khurshid M Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):703-6. PubMed ID: 9253870 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis--Brazil. Treitinger A; Spada C; Ferreira LA; Neto MS; Reis M; Verdi JC; de Miranda AF; de Oliveira OV; Van der Sander Silveira M; Abdalla DS Braz J Infect Dis; 2000 Aug; 4(4):192-6. PubMed ID: 11008223 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore. Kuperan P; Choon AT; Ding SH; Lee G Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946 [TBL] [Abstract][Full Text] [Related]
8. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [TBL] [Abstract][Full Text] [Related]
9. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866 [TBL] [Abstract][Full Text] [Related]
10. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848 [TBL] [Abstract][Full Text] [Related]
11. [Prevalence of HBV and HCV infections in plasma donors with recently increased ALT level]. Li F Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):217-9. PubMed ID: 7511485 [TBL] [Abstract][Full Text] [Related]
12. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of anti-HCV among voluntary blood donors in Taiwan. Tsai SJ; Chen CJ; Hsieh YS; Yang CS Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):61-70. PubMed ID: 1657546 [TBL] [Abstract][Full Text] [Related]
15. [Prevalence of HBsAg, anti-HBc and anti-HCV in blood donor candidates at the Campinas hemocenter]. Gonçales Júnior FL; Boccato RS; Pedro Rde J; Papaiordanou PM; de Souza CA; Gonçales NS; Pellegrino Júnior J Rev Inst Med Trop Sao Paulo; 1993; 35(1):45-51. PubMed ID: 7506445 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C]. Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B and C prevalences among blood donors in the south region of Brazil. Vasconcelos HC; Yoshida CF; Vanderborght BO; Schatzmayr HG Mem Inst Oswaldo Cruz; 1994; 89(4):503-7. PubMed ID: 8524053 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005 [TBL] [Abstract][Full Text] [Related]
19. Frequency of hepatitis C virus antibodies and elevated serum alanine transaminase levels in Ghanaian blood donors. Acquaye JK; Tettey-Donkor D West Afr J Med; 2000; 19(4):239-41. PubMed ID: 11391831 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels. Hetland G; Skaug K; Larsen J; Maland A; Strømme JH; Størvold G Transfusion; 1990; 30(9):776-9. PubMed ID: 2173175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]